StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.23−0.01 (-0.15%)

Close on Nov 18, 2026Market cap $140.15MP/E –Yield –

Drugs Made In America Acquisition II market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Drugs Made In America Acquisition II's market cap was $140.29M on Nov 11, 2026.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$140.29M-9.0%
2025Dec 31, 2025$154.19M–

More Drugs Made In America Acquisition II figures

See a number that looks wrong?